Literature DB >> 3129525

Production of gamma interferon by cultured human lymphocytes stimulated with a purified membrane protein (P30) from Toxoplasma gondii.

I A Khan1, M E Eckel, E R Pfefferkorn, L H Kasper.   

Abstract

Purified P30, the principal iodinatable membrane protein of Toxoplasma gondii, induced proliferation of peripheral blood mononuclear cells from seropositive individuals but not from seronegative individuals. Culture supernatants from stimulated cells of seropositive individuals blocked the growth of T. gondii in human fibroblasts, whereas those from antibody-negative individuals failed to do so. The anti-toxoplasmic effect of culture supernatants correlated with the induction of indoleamine 2,3-dioxygenase and the destruction of tryptophan, as previously described for fibroblasts treated with recombinant gamma interferon (IFN-gamma). The anti-toxoplasmic effect was blocked by monoclonal antibody to IFN-gamma. The protective effect correlated with the amount of IFN-gamma in the culture supernatant, as measured by inhibition of viral CPE. Thus, the level of IFN-gamma appears to be an important immune factor in protection against toxoplasmosis in humans.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3129525     DOI: 10.1093/infdis/157.5.979

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Protective immunity against Toxoplasma gondii in mice induced by a chimeric protein rSAG1/2.

Authors:  Chung-Dar Yang; Gan-Nan Chang; David Chao
Journal:  Parasitol Res       Date:  2003-11-06       Impact factor: 2.289

2.  Structural and functional characterization of SporoSAG: a SAG2-related surface antigen from Toxoplasma gondii.

Authors:  Joanna Crawford; Erika Lamb; James Wasmuth; Ognjen Grujic; Michael E Grigg; Martin J Boulanger
Journal:  J Biol Chem       Date:  2010-02-17       Impact factor: 5.157

3.  Presence of gamma interferon in human acute and congenital toxoplasmosis.

Authors:  J Raymond; M H Poissonnier; P H Thulliez; F Forestier; F Daffos; P Lebon
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

4.  Toxoplasmacidal activity of macrophages activated by recombinant major surface antigen (P30) of Toxoplasma gondii.

Authors:  A Makioka; A Kobayashi
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

5.  Epitopes recognized by human T lymphocytes in the ROP2 protein antigen of Toxoplasma gondii.

Authors:  R Saavedra; M A Becerril; C Dubeaux; R Lippens; M J De Vos; P Hérion; A Bollen
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

6.  Establishment of T-helper type 1- and T-helper type 2-like human Toxoplasma antigen-specific T-cell clones.

Authors:  W Däubener; C Mackenzie; U Hadding
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

7.  CD4+ T cells in the pathogenesis of murine ocular toxoplasmosis.

Authors:  Fangli Lu; Shiguang Huang; Lloyd H Kasper
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

Review 8.  Role of gamma interferon in Toxoplasma gondii infection.

Authors:  C S Subauste; J S Remington
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

9.  Induction of antigen-specific human cytotoxic T cells by Toxoplasma gondii.

Authors:  I A Khan; K A Smith; L H Kasper
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

10.  Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii.

Authors:  C Bonenfant; I Dimier-Poisson; F Velge-Roussel; D Buzoni-Gatel; G Del Giudice; R Rappuoli; D Bout
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.